Genetic and Pharmacological Inhibition of PDK1 in Cancer Cells
Kumiko Nagashima(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jannik N. Andersen(Tango Therapeutics (United States))
Cited by 66
Related Papers
Development of novel cellular histone-binding and chromatin-displacement assays for bromodomain drug discovery
|Epigenetics & Chromatin|2015|40